Johnson & Johnson (
) will begin trading ex-dividend on February 21, 2014. A cash
dividend payment of $0.66 per share is scheduled to be paid on
March 11, 2014. Shareholders who purchased JNJ stock prior to the
ex-dividend date are eligible for the cash dividend payment. This
marks the 4th quarter that JNJ has paid the same dividend.
The previous trading day's last sale of JNJ was $91.64,
representing a -4.53% decrease from the 52 week high of $95.99 and
a 21.38% increase over the 52 week low of $75.50.
JNJ is a part of the Health Care sector, which includes
companies such as Pfizer, Inc. (
) and Novartis AG (
). JNJ's current earnings per share, an indicator of a company's
profitability, is $4.82. Zacks Investment Research reports JNJ's
forecasted earnings growth in 2014 as 5.65%, compared to an
industry average of -.6%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to JNJ through an Exchange
Traded Fund [ETF]?
The following ETF(s) have JNJ as a top-10 holding:
- Merrill Lynch Pharmaceutical HOLDRS (
- Select Sector SPDR Fund - Health Care (
- iShares U.S. Pharmaceutical ETF (
- iShares Dow Jones U.S. Health Care Index Fund (
- Vanguard Health Care ETF (
The top-performing ETF of this group is IHE with an increase of
22.05% over the last 100 days. PPH has the highest percent
weighting of JNJ at 9.15%.